国泰君安创新医药混合发起A(014157)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2024-12-30 |
130,100,275.66 |
159,307,434.49 |
38,368,143.24 |
9,160,984.41 |
| 2024-09-29 |
135,691,976.08 |
130,100,275.66 |
767,994.64 |
6,359,695.06 |
| 2024-06-29 |
133,361,885.52 |
135,691,976.08 |
7,533,782.55 |
5,203,691.99 |
| 2024-03-30 |
139,837,615.31 |
133,361,885.52 |
2,587,089.07 |
9,062,818.86 |
| 2023-12-30 |
141,668,136.51 |
139,837,615.31 |
9,214,538.77 |
11,045,059.97 |
| 2023-09-29 |
126,915,647.86 |
141,668,136.51 |
28,607,800.27 |
13,855,311.62 |
| 2023-06-29 |
196,202,472.21 |
126,915,647.86 |
15,818,367.25 |
85,105,191.60 |
| 2023-03-30 |
34,633,053.51 |
196,202,472.21 |
204,067,853.37 |
42,498,434.67 |
| 2022-12-30 |
31,955,118.81 |
34,633,053.51 |
3,468,004.08 |
790,069.38 |
| 2022-09-29 |
32,016,484.25 |
31,955,118.81 |
1,378,409.61 |
1,439,775.05 |
| 2022-06-29 |
32,158,843.41 |
32,016,484.25 |
167,466.04 |
309,825.20 |
| 2022-03-30 |
32,163,118.84 |
32,158,843.41 |
62,524.29 |
66,799.72 |
微信公众号
证券之星APP
基本资料
